2023 FIRST LOOK | Mark Albers, MD, PhD

preview_player
Показать описание
TYK2 as a novel therapeutic target in a subset of Alzheimer’s Disease with neuroinflammation

Mark Albers, MD, PhD
Frank Wilkens Jr and Family Endowed Scholar in AD Research, MGH; Assistant Professor of Neurology, HMS
Рекомендации по теме